Literature DB >> 8981294

Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases.

R A Rangel-Guerra1, H R Martínez, C Sáenz, F Bosques-Padilla, I Estrada-Bellmann.   

Abstract

We analysed retrospectively our clinical experience with 36 cases of mucormycosis. They were seen during the last 15 years. The diagnosis suspected on clinical grounds, was confirmed in 31 cases by finding the hyphae in hematoxylin-eosin stained material obtained from aspirated or tissue biopsy or by isolation of the fungus in culture. Rhinocerebral mucormycosis was diagnosed in 22 patients. Diabetes was the underlying disorder in 20 cases, kidney failure in one and myelodysplastic syndrome in one. Nine had stable and 11 unstable diabetes (ketoacidosis in 10 and hyperosmolar coma in 1). The earliest sign was facial edema, followed by proptosis, chemosis and extraocular muscle paresis. They were treated by extensive surgical debridement, insulin and antifungal drugs with 69% of survival rate. The disseminated mucormycosis was diagnosed at the autopsy in 5 cases, acute leukemia was the underlying disease in 2 of them. Pulmonary mucormycosis was diagnosed in 2 cases, cutaneous form in 2, sinuorbital form in 4 and brain abscess in one patient. Eight of these 9 cases survived after therapy. We emphasize the importance of an early diagnosis. This can only be made in the presence of a typical clinical setting confirmed by finding the hyphae in tissue or culture. Antifungal drugs along with treatment of the underlying disorder and aggressive surgical debridement must follow.

Entities:  

Mesh:

Year:  1996        PMID: 8981294     DOI: 10.1016/s0022-510x(96)00148-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Clinical and surgical implications regarding morphometric variations of the medial wall of the orbit in relation to age and gender.

Authors:  Rodolfo Morales-Avalos; Arlette Gabriela Santos-Martínez; Cesia Gisela Ávalos-Fernández; Karim Mohamed-Noriega; Gabriela Sánchez-Mejorada; Adolfo Montemayor-Alatorre; David A Martínez-Fernández; Abraham G Espinosa-Uribe; Jibran Mohamed-Noriega; Edgar E Cuervo-Lozano; Jesús Mohamed-Hamsho; Oscar Quiroga-García; Roberto A Lugo-Guillen; Santos Guzmán-López; Rodrigo E Elizondo-Omaña
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-18       Impact factor: 2.503

Review 2.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

4.  Imaging findings of rhinocerebral mucormycosis.

Authors:  Diego A Herrera; Arthur B Dublin; Eleanor L Ormsby; Shervin Aminpour; Lydia P Howell
Journal:  Skull Base       Date:  2009-03

5.  Vaginal mucormycosis: a case report.

Authors:  J D Sobel
Journal:  Infect Dis Obstet Gynecol       Date:  2001

6.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498

7.  Optic nerve thickening and infarction as the first evidence of orbital involvement with mucormycosis.

Authors:  Adel H Alsuhaibani; Ghazai Al-Thubaiti; Fahad B Al Badr
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Jul-Sep

8.  Clinical features and outcome of mucormycosis.

Authors:  Carlos Rodrigo Camara-Lemarroy; Emmanuel Irineo González-Moreno; René Rodríguez-Gutiérrez; Erick Joel Rendón-Ramírez; Ana Sofía Ayala-Cortés; Martha Lizeth Fraga-Hernández; Laura García-Labastida; Dionicio Ángel Galarza-Delgado
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.